ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      84.85
      0.00%
      Bitcoin
      61,466.25
      0.94%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. GeoVax Labs Inc (GOVXW)

      7. GeoVax Labs Inc (GOVXW) News

      GOVXW

      GeoVax Labs (GOVXW)

      GeoVax Labs Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:GOVXW
      DateTimeSourceHeadlineSymbolCompany
      05/25/20221:47PMGlobeNewswire Inc.GeoVax Announces $20 Million Registered Direct and PIPE Offerings Priced at a Premium to Market Under Nasdaq RulesNASDAQ:GOVXWGeoVax Labs Inc
      05/24/20229:00AMGlobeNewswire Inc.GeoVax Receives Notice of Allowance for Cancer Vaccine Patent in ChinaNASDAQ:GOVXWGeoVax Labs Inc
      05/04/20229:00AMGlobeNewswire Inc.GeoVax Announces Upcoming Presentations at Scientific ConferencesNASDAQ:GOVXWGeoVax Labs Inc
      04/27/20224:00PMGlobeNewswire Inc.GeoVax Reports 2022 First Quarter Financial Results and Provides Corporate UpdateNASDAQ:GOVXWGeoVax Labs Inc
      04/26/20229:00AMGlobeNewswire Inc.GeoVax Announces Issuance of Malaria Vaccine PatentNASDAQ:GOVXWGeoVax Labs Inc
      04/19/20229:00AMGlobeNewswire Inc.GeoVax to Report First Quarter 2022 Financial Results on Wednesday, April 27, 2022 and Provide Corporate UpdateNASDAQ:GOVXWGeoVax Labs Inc
      04/18/20225:52PMGlobeNewswire Inc.CORRECTION - Aura FAT Projects Acquisition Corp. Announces Closing of Initial Public Offering and Exercise of Full Over-Allotment OptionNASDAQ:GOVXWGeoVax Labs Inc
      04/18/20224:05PMGlobeNewswire Inc.Aura FAT Projects Acquisition Corp. Announces Closing of Initial Public Offering and Exercise of Full Over-Allotment OptionNASDAQ:GOVXWGeoVax Labs Inc
      04/12/20229:00AMGlobeNewswire Inc.GeoVax to Participate in Expert Panel Discussion on Pan-Corona and Universal Vaccines at the World Vaccine CongressNASDAQ:GOVXWGeoVax Labs Inc
      03/22/20229:00AMGlobeNewswire Inc.GeoVax Announces Issuance of Cancer Vaccine PatentNASDAQ:GOVXWGeoVax Labs Inc
      03/21/20229:00AMGlobeNewswire Inc.GeoVax to Present COVID-19 Vaccine Data at the Vaccine Summit Boston 2022NASDAQ:GOVXWGeoVax Labs Inc
      03/16/20229:00AMGlobeNewswire Inc.GeoVax to Participate in Maxim Group’s 2022 Virtual Growth ConferenceNASDAQ:GOVXWGeoVax Labs Inc
      03/14/20229:00AMGlobeNewswire Inc.GeoVax Retains CATO SMS to Manage Two Phase 2 COVID-19 Vaccine Clinical TrialsNASDAQ:GOVXWGeoVax Labs Inc
      03/10/20229:00AMGlobeNewswire Inc.Data Published in a Lancet Journal on COH04S1, a City of Hope-Developed COVID-19 Vaccine, Shows it Produced Robust Antibodies and T cells Against SARS-CoV-2NASDAQ:GOVXWGeoVax Labs Inc
      03/09/20224:00PMGlobeNewswire Inc.GeoVax Reports 2021 Year-End Financial Results and Provides Corporate UpdateNASDAQ:GOVXWGeoVax Labs Inc
      03/07/20229:00AMGlobeNewswire Inc.GeoVax Announces Key Staff AppointmentsNASDAQ:GOVXWGeoVax Labs Inc
      02/23/20229:00AMGlobeNewswire Inc.GeoVax to Report 2021 Financial Results on Wednesday, March 9, 2022 and Provide Corporate UpdateNASDAQ:GOVXWGeoVax Labs Inc
      02/22/20221:00PMGlobeNewswire Inc.GeoVax CEO Selected as a Recipient of the 2022 Georgia Titan 100NASDAQ:GOVXWGeoVax Labs Inc
      02/08/20229:00AMGlobeNewswire Inc.GeoVax to Present at the 2022 BIO CEO & Investor Digital ConferenceNASDAQ:GOVXWGeoVax Labs Inc
      01/20/20229:00AMGlobeNewswire Inc.GeoVax Announces Closing of $10 Million Private PlacementNASDAQ:GOVXWGeoVax Labs Inc
      01/14/20228:41AMGlobeNewswire Inc.GeoVax Announces $10 Million Private PlacementNASDAQ:GOVXWGeoVax Labs Inc
      01/13/20229:00AMGlobeNewswire Inc.GeoVax Retains CATO SMS to Manage Gedeptin® Phase 1/2 Clinical TrialNASDAQ:GOVXWGeoVax Labs Inc
      01/11/20229:00AMGlobeNewswire Inc.GeoVax Appoints Dr. Kelly McKee as Chief Medical OfficerNASDAQ:GOVXWGeoVax Labs Inc
      01/05/20229:00AMGlobeNewswire Inc.GeoVax to Participate in Upcoming Life Sciences Investor ConferencesNASDAQ:GOVXWGeoVax Labs Inc
      01/04/20229:00AMGlobeNewswire Inc.GeoVax Issues Shareholder Update LetterNASDAQ:GOVXWGeoVax Labs Inc
      12/15/20219:00AMGlobeNewswire Inc.GeoVax Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine BoosterNASDAQ:GOVXWGeoVax Labs Inc
      12/14/20219:00AMGlobeNewswire Inc.GeoVax Receives Notice of Allowance for Malaria Vaccine PatentNASDAQ:GOVXWGeoVax Labs Inc
      12/03/20219:00AMGlobeNewswire Inc.GeoVax Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy CongressNASDAQ:GOVXWGeoVax Labs Inc
      12/01/20219:00AMGlobeNewswire Inc.GeoVax Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy CongressNASDAQ:GOVXWGeoVax Labs Inc
      11/17/20219:00AMGlobeNewswire Inc.GeoVax Presents COVID-19 Vaccine Data at the Vaccine World Asia CongressNASDAQ:GOVXWGeoVax Labs Inc
       Showing the most relevant articles for your search:NASDAQ:GOVXW